Web Results

Febuxostat - Wikipedia


Febuxostat is a drug that inhibits xanthine oxidase, thus reducing production of uric acid in the body. It is used in the treatment of chronic gout and hyperuricemia  ...

Febuxostat: Indications, Side Effects, Warnings - Drugs.com


Jan 6, 2017 ... Easy to read patient leaflet for febuxostat. Includes indications, proper use, special instructions, precautions, and possible side effects.

febuxostat oral : Uses, Side Effects, Interactions, Pictures, Warnings ...


Find patient medical information for febuxostat oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Uloric (Febuxostat): Side Effects, Interactions, Warning, Dosage ...


Learn about Uloric (Febuxostat) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.

Febuxostat: MedlinePlus Drug Information


Oct 15, 2016 ... Febuxostat: learn about side effects, dosage, special precautions, and more on MedlinePlus.

Common Side Effects of Uloric (Febuxostat) Drug Center - RxList


Sep 23, 2016 ... Uloric (febuxostat) is a xanthine oxidase inhibitor used to treat excess uric acid in the blood (hyperuricemia) in patients with gout. Side effects of ...

Uloric (Febuxostat) Drug Information: Indications, Dosage and How ...


Learn about indications, dosage and how it is supplied for the drug Uloric ( Febuxostat).

febuxostat, Uloric: Drug Facts, Side Effects and Dosing - MedicineNet


Sep 11, 2015 ... Information about febuxostat (Uloric), a drug prescribed for the treatment of hyperuricemia in individuals with gout. Side effects, dosing, and ...

Febuxostat | Arthritis Research UK


Febuxostat is used for the long-term treatment and prevention of gout. In this section we explain how febuxostat works, what you should expect from the ...

Febuxostat, a novel nonpurine selective inhibitor of xanthine ... - NCBI


Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty- eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, ...